Core Laboratories NV (CLB)

Cash ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Cash and cash equivalents	US$ in thousands	15,120	16,616	26,204
Short-term investments	US$ in thousands	—	—	—
Total current liabilities	US$ in thousands	88,097	84,250	96,194
Cash ratio		0.17	0.20	0.27

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($15,120K + $—K) ÷ $88,097K
= 0.17

The cash ratio of Core Laboratories NV has been fluctuating over the past three quarters. As of December 31, 2023, the company's cash ratio stands at 0.17, indicating that it has $0.17 of cash and cash equivalents for every $1 of current liabilities. This suggests that Core Laboratories NV may have limited short-term liquidity to cover its immediate obligations.

Comparing this to the previous quarters, the cash ratio was slightly higher at 0.20 on September 30, 2023, and highest at 0.27 on June 30, 2023. The downward trend in the cash ratio from June to December could raise concerns about the company's ability to meet its short-term liabilities solely based on its cash reserves.

It is important for investors and stakeholders to monitor the company's cash position closely, as a declining cash ratio may signal potential liquidity issues that could impact the company's financial health and operations.